Episode 14- Recent Trends in the Epidemiology of Cardiometabolic Conditions

Despite factors that include a current population of people who are obese and do not exercise or eat as healthy as recommended, Michael Weber, MD, explains that the epidemiology of cardiometabolic conditions has improved due to the developments of more tolerable, effective pharmaceutical agents.

Dr Weber continues by discussing how there has been a decline in cardiovascular events thanks to these agents, which most notably have improved the outlook on hypertension and lipid disorders.

However, when assessing which cardiometabolic conditions have improved the most, Dr Weber concludes that diabetes is lagging behind and determines that more effective treatments for diabetes are necessary.